| Date Filed | Type | Description |
| 08/18/2023 |
4
| Duncan Gregory Scott (CEO) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Bought 25,000 shares
@ $1.2498, valued at
$31.2k
|
|
| 01/18/2023 |
4
| Duncan Gregory Scott (Director) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 20,000 options to buy
@ $4.43, valued at
$88.6k
|
|
| 12/14/2022 |
4
| Duncan Gregory Scott (CEO) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Granted 480,000 options to buy
@ $0.2789, valued at
$133.9k
|
|
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2020 |
4
| Duncan Gregory Scott (CEO) has filed a Form 4 on Virios Therapeutics, Inc.|
Txns:
| Granted 414,125 options to buy
@ $10, valued at
$4.1M
|
|
| 12/16/2020 |
3
| Duncan Gregory Scott (CEO) has filed a Form 3 on Virios Therapeutics, LLC |
| 11/04/2020 |
4
| Duncan Gregory Scott (Director) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 20,000 options to buy
@ $5, valued at
$100k
Granted 2,500 options to buy
@ $5, valued at
$12.5k
|
|
| 11/04/2020 |
3
| Duncan Gregory Scott (Director) has filed a Form 3 on CorMedix Inc. |